To evaluate functional relationships between ALDH1A3High cells, melanoma disease progression, and therapy resistance, we employed the widely used BRAFV600E p53 mutant zebrafish melanoma model, in which BRAF inhibitors initially reduce tumor burden followed by drug resistance and recurrent melanoma growth.79 This evidence concerns the gene TP53 and neoplasm.